Syschem India Ltd — Updates, 04-08-2025: Company Update

Syschem (India) Limited, a bulk drug and intermediates manufacturer, is expanding its operations. The company is constructing a new WHO-GMP compliant manufacturing unit in Kalka, Haryana, to significantly increase production capacity for key antibiotics like cloxacillin, dicloxacillin, and flucloxacillin, reinforcing its global API supplier position. Financially, the company reported a 24% revenue increase for the latest quarter compared to the prior year's same quarter. While revenue dipped modestly compared to the immediate preceding quarter due to weaker demand, it saw improved EBITDA and achieved a PBT of 1.674 Cr in the recent quarter, demonstrating quarter-on-quarter growth. Production volume also significantly scaled up by 81% compared to the prior year's same quarter.